Exelixis Long Term Debt 2006-2020 | EXEL

Exelixis long term debt from 2006 to 2020. Long term debt can be defined as the sum of all long term debt fields.
  • Exelixis long term debt for the quarter ending June 30, 2020 was $M, a 100% decline year-over-year.
  • Exelixis long term debt for 2019 was $0B, a NAN% decline from 2018.
  • Exelixis long term debt for 2018 was $0B, a 100% decline from 2017.
  • Exelixis long term debt for 2017 was $0.015B, a INF% increase from 2016.
Exelixis Annual Long Term Debt
(Millions of US $)
2019 $
2018 $
2017 $15
2016 $
2015 $418
2014 $264
2013 $345
2012 $337
2011 $186
2010 $178
2009 $40
2008 $75
2007 $106
2006 $108
2005 $107
Exelixis Quarterly Long Term Debt
(Millions of US $)
2020-06-30
2020-03-31
2019-12-31
2019-09-30 $24
2019-06-30 $23
2019-03-31 $20
2018-12-31
2018-09-30 $13
2018-06-30
2018-03-31
2017-12-31 $15
2017-09-30
2017-06-30
2017-03-31
2016-12-31
2016-09-30 $81
2016-06-30 $289
2016-03-31 $362
2015-12-31 $418
2015-09-30 $380
2015-06-30 $374
2015-03-31 $368
2014-12-31 $264
2014-09-30 $263
2014-06-30 $260
2014-03-31 $350
2013-12-31 $345
2013-09-30 $340
2013-06-30 $335
2013-03-31 $331
2012-12-31 $337
2012-09-30 $329
2012-06-30 $177
2012-03-31 $177
2011-12-31 $186
2011-09-30 $183
2011-06-30 $181
2011-03-31 $180
2010-12-31 $178
2010-09-30 $198
2010-06-30 $198
2010-03-31 $38
2009-12-31 $40
2009-09-30 $67
2009-06-30 $69
2009-03-31 $72
2008-12-31 $75
2008-09-30 $106
2008-06-30 $110
2008-03-31 $103
2007-12-31 $106
2007-09-30 $100
2007-06-30 $103
2007-03-31 $106
2006-12-31 $108
2006-09-30 $101
2006-06-30 $103
2006-03-31 $106
2005-12-31 $107
2005-09-30 $105
2005-06-30 $107
2005-03-31 $134
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $7.366B $0.968B
Exelixis, Inc. is a biopharmaceutical company committed to developing small molecule therapies for the treatment of cancer. Exelixis is focusing its development and commercialization efforts primarily on COMETRIQ? (cabozantinib), its wholly-owned inhibitor of multiple receptor tyrosine kinases. Another Exelixis-discovered compound, cobimetinib, a selective inhibitor of MEK, is being evaluated by Roche and Genentech (a member of the Roche Group) in a broad development program under a collaboration with Exelixis.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $142.804B 15.51
Bristol Myers Squibb (BMY) United States $134.607B 10.36
CSL (CSLLY) Australia $95.723B 0.00
Gilead Sciences (GILD) United States $78.044B 11.24
Vertex Pharmaceuticals (VRTX) United States $69.852B 38.98
Regeneron Pharmaceuticals (REGN) United States $61.076B 23.35
Illumina (ILMN) United States $43.784B 50.92
Biogen (BIIB) United States $43.264B 7.40
Seattle Genetics (SGEN) United States $32.181B 0.00
Moderna (MRNA) United States $27.412B 0.00
BeiGene (BGNE) Cayman Islands $25.529B 0.00
Alexion Pharmaceuticals (ALXN) United States $25.080B 10.45
Genmab (GMAB) Denmark $23.560B 14.88
Genmab (GNMSF) Denmark $22.160B 5.10
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $20.865B 0.00
Immunomedics (IMMU) United States $19.730B 0.00
Incyte (INCY) United States $18.928B 0.00
Horizon Therapeutics Public (HZNP) Ireland $16.156B 37.80
Alnylam Pharmaceuticals (ALNY) United States $16.040B 0.00
BioNTech SE (BNTX) Germany $15.089B 0.00
Bio-Rad Laboratories (BIO.B) United States $15.077B 68.19
Exact Sciences (EXAS) United States $14.671B 0.00
BioMarin Pharmaceutical (BMRN) United States $14.035B 101.83
QIAGEN (QGEN) Netherlands $11.825B 30.01
ARGENX SE-ADR (ARGX) Netherlands $11.685B 0.00
Sarepta Therapeutics (SRPT) United States $11.305B 0.00
Guardant Health (GH) United States $11.116B 0.00
Bio-Techne Corp (TECH) United States $9.321B 63.95
Galapagos (GLPG) Belgium $9.081B 32.90
Ascendis Pharma (ASND) Denmark $8.140B 0.00
Repligen (RGEN) United States $7.576B 120.25
Mirati Therapeutics (MRTX) United States $7.450B 0.00
SWEDISH ORP BIO (BIOVF) Sweden $7.304B 18.17
MyoKardia (MYOK) United States $7.035B 0.00
Novavax (NVAX) United States $6.959B 0.00
Adaptive Biotechnologies (ADPT) United States $6.557B 0.00
Acceleron Pharma (XLRN) United States $6.477B 0.00
ACADIA Pharmaceuticals (ACAD) United States $6.336B 0.00
Momenta Pharmaceuticals (MNTA) United States $6.237B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $5.901B 182.80
Emergent Biosolutions (EBS) United States $5.379B 21.31
Ultragenyx Pharmaceutical (RARE) United States $4.973B 0.00
Blueprint Medicines (BPMC) United States $4.864B 0.00
Zai Lab (ZLAB) China $4.609B 0.00
Vir Biotechnology (VIR) United States $4.563B 0.00
China Biologic Products (CBPO) China $4.349B 25.82
Arena Pharmaceuticals (ARNA) United States $4.248B 0.00
MorphoSys AG (MOR) Germany $4.163B 54.55
Legend Biotech (LEGN) United States $4.018B 0.00
NeoGenomics (NEO) United States $3.956B 1194.00
Bluebird Bio (BLUE) United States $3.777B 0.00
Denali Therapeutics (DNLI) United States $3.724B 0.00
Halozyme Therapeutics (HALO) United States $3.571B 0.00
Amicus Therapeutics (FOLD) United States $3.570B 0.00
Insmed (INSM) United States $3.411B 0.00
Global Blood Therapeutics (GBT) United States $3.325B 0.00
Principia Biopharma (PRNB) United States $3.323B 0.00
Fate Therapeutics (FATE) United States $3.283B 0.00
Twist Bioscience (TWST) United States $3.244B 0.00
Reata Pharmaceuticals (RETA) United States $3.153B 0.00
Inovio Pharmaceuticals (INO) United States $2.838B 0.00
Deciphera Pharmaceuticals (DCPH) United States $2.800B 0.00
Alkermes (ALKS) Ireland $2.662B 55.80
Sorrento Therapeutics (SRNE) United States $2.332B 0.00
PHARMA MAR SA (PHMMF) Spain $2.208B 0.00
I-Mab (IMAB) China $2.181B 0.00
Zymeworks (ZYME) Canada $2.061B 0.00
Mesoblast (MESO) Australia $2.058B 0.00
Forma Therapeutics Holdings (FMTX) United States $2.035B 0.00
Seres Therapeutics (MCRB) United States $2.010B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $1.926B 21.57
Akcea Therapeutics (AKCA) United States $1.843B 0.00
Editas Medicine (EDIT) United States $1.831B 0.00
Intra-Cellular Therapies (ITCI) United States $1.809B 0.00
Eidos Therapeutics (EIDX) United States $1.738B 0.00
Revance Therapeutics (RVNC) United States $1.719B 0.00
UniQure (QURE) Netherlands $1.660B 0.00
Cytokineticsorporated (CYTK) United States $1.650B 0.00
Ligand Pharmaceuticals (LGND) United States $1.562B 52.81
Amarin (AMRN) Ireland $1.469B 0.00
Viela Bio (VIE) United States $1.468B 0.00
Zealand Pharma (ZEAL) Denmark $1.411B 0.00
Sangamo Therapeutics (SGMO) United States $1.406B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.390B 0.00
Beam Therapeutics (BEAM) United States $1.384B 0.00
Zealand Pharma (ZLDPF) Denmark $1.339B 0.00
Intercept Pharmaceuticals (ICPT) United States $1.333B 0.00
Mersana Therapeutics (MRSN) United States $1.331B 0.00
Coherus BioSciences (CHRS) United States $1.316B 7.67
Intellia Therapeutics (NTLA) United States $1.250B 0.00
Epizyme (EPZM) United States $1.212B 0.00
Arcus Biosciences (RCUS) United States $1.148B 0.00
NGM Biopharmaceuticals (NGM) United States $1.129B 0.00
Compugen (CGEN) Israel $1.101B 0.00
REGENXBIO (RGNX) United States $1.040B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.030B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $1.024B 0.00
Athenex (ATNX) United States $1.013B 0.00
Alcobra (ARCT) United States $0.978B 0.00
Castle Biosciences (CSTL) United States $0.977B 0.00
Arvinas (ARVN) United States $0.958B 0.00
Heska (HSKA) United States $0.931B 0.00
Retrophin (RTRX) United States $0.931B 0.00
Myriad Genetics (MYGN) United States $0.929B 0.00
Genetron Holdings (GTH) China $0.897B 0.00
Alector (ALEC) United States $0.895B 0.00
Adverum Biotechnologies (ADVM) United States $0.872B 0.00
Vericel (VCEL) United States $0.827B 0.00
Morphic Holding (MORF) United States $0.820B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.788B 0.00
NantKwest (NK) United States $0.775B 0.00
Pliant Therapeutics (PLRX) United States $0.763B 0.00
Cellectis S.A (CLLS) France $0.758B 0.00
Agenus (AGEN) United States $0.737B 0.00
Protagonist Therapeutics (PTGX) United States $0.735B 0.00
VBI Vaccines (VBIV) United States $0.712B 0.00
MiMedx (MDXG) United States $0.706B 0.00
Codexis (CDXS) United States $0.698B 0.00
Frequency Therapeutics (FREQ) United States $0.690B 0.00
Pharming Group (PHGUF) Netherlands $0.682B 15.57
Kadmon Holdings (KDMN) United States $0.650B 0.00
Sinovac Biotech (SVA) China $0.640B 43.13
Intrexon (PGEN) United States $0.617B 0.00
Cara Therapeutics (CARA) United States $0.607B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.596B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.574B 0.00
Northwest Biotherapeutics (NWBO) United States $0.568B 0.00
Forte Biosciences (FBRX) United States $0.549B 0.00
Scholar Rock Holding (SRRK) United States $0.539B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.536B 0.00
Geron (GERN) United States $0.525B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.525B 0.00
Clovis Oncology (CLVS) United States $0.519B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.509B 4.46
Celldex Therapeutics (CLDX) United States $0.501B 0.00
Albireo Pharma (ALBO) United States $0.499B 0.00
Dynavax Technologies (DVAX) United States $0.491B 0.00
Anika Therapeutics (ANIK) United States $0.486B 21.25
Aquinox Pharmaceuticals (NLTX) United States $0.485B 0.00
IVERIC Bio (ISEE) United States $0.477B 0.00
Cue Biopharma (CUE) United States $0.477B 0.00
MeiraGTx Holdings (MGTX) United States $0.460B 0.00
Kala Pharmaceuticals (KALA) United States $0.436B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.430B 0.00
Starpharma Holdings (SPHRY) Australia $0.427B 0.00
Avid Bioservices (CDMO) United States $0.425B 0.00
MannKind (MNKD) United States $0.424B 0.00
Syros Pharmaceuticals (SYRS) United States $0.420B 0.00
Amryt Pharma (AMYT) United Kingdom $0.407B 0.00
Prothena (PRTA) Ireland $0.405B 0.00
UROGEN PHARMA (URGN) United States $0.404B 0.00
Athersys (ATHX) United States $0.403B 0.00
AnaptysBio (ANAB) United States $0.399B 0.00
Puma Biotechnology (PBYI) United States $0.389B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.385B 0.00
BioDelivery Sciences (BDSI) United States $0.381B 26.93
Kamada (KMDA) Israel $0.375B 17.92
PDL BioPharma (PDLI) United States $0.373B 0.00
Trevena (TRVN) United States $0.373B 0.00
Sutro Biopharma (STRO) United States $0.370B 0.00
Cellular Biomedicine (CBMG) United States $0.358B 0.00
Fortress Biotech (FBIO) United States $0.356B 0.00
Merus (MRUS) Netherlands $0.350B 0.00
AC Immune SA (ACIU) Switzerland $0.343B 0.00
WAVE Life Sciences (WVE) Singapore $0.338B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.336B 0.00
ANI Pharmaceuticals (ANIP) United States $0.336B 7.92
Precision BioSciences (DTIL) United States $0.321B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.315B 0.00
CytomX Therapeutics (CTMX) United States $0.314B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.308B 0.00
Innate Pharma S.A (IPHA) France $0.305B 0.00
OSMOTICA PHARM (OSMT) United States $0.270B 0.00
Cardiff Oncology (CRDF) United States $0.264B 0.00
Prometic Life Sciences (LMNL) Canada $0.261B 0.00
Selecta Biosciences (SELB) United States $0.259B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.259B 0.00
Affimed (AFMD) Germany $0.254B 0.00
Arbutus Biopharma (ABUS) United States $0.249B 0.00
ChromaDex (CDXC) United States $0.248B 0.00
Pluristem Therapeutics (PSTI) Israel $0.247B 0.00
Cyclerion Therapeutics (CYCN) United States $0.231B 0.00
NextCure (NXTC) United States $0.231B 0.00
TELA Bio (TELA) United States $0.222B 0.00
HOOKIPA Pharma (HOOK) United States $0.217B 0.00
Verastem (VSTM) United States $0.215B 0.00
XOMA (XOMA) United States $0.208B 0.00
Dyadic (DYAI) United States $0.204B 0.00
Spero Therapeutics (SPRO) United States $0.202B 0.00
Liquidia Technologies (LQDA) United States $0.191B 0.00
Aduro Biotech (ADRO) United States $0.190B 0.00
ADMA Biologics Inc (ADMA) United States $0.188B 0.00
POXEL SA FRANCE (PXXLF) France $0.188B 0.00
Cerecor (CERC) United States $0.182B 0.00
Kindred Biosciences (KIN) United States $0.176B 0.00
DBV Technologies S.A (DBVT) France $0.176B 0.00
Biofrontera AG (BFRA) Germany $0.175B 0.00
Eton Pharmaceuticals (ETON) United States $0.174B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.172B 0.00
Theratechnologies (THTX) Canada $0.171B 0.00
Checkpoint Therapeutics (CKPT) United States $0.169B 0.00
Five Prime Therapeutics (FPRX) United States $0.164B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.163B 7.60
GENFIT S.A (GNFT) France $0.159B 0.00
Abeona Therapeutics (ABEO) United States $0.158B 0.00
Exicure (XCUR) United States $0.153B 0.00
SESEN BIO, INC (SESN) United States $0.152B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.151B 0.00
AquaBounty Technologies (AQB) United States $0.149B 0.00
Nicox SA (NICXF) France $0.149B 0.00
Aptinyx (APTX) United States $0.147B 0.00
Aytu Bioscience (AYTU) United States $0.142B 0.00
Bellus Health (BLU) Canada $0.131B 0.00
Cidara Therapeutics (CDTX) United States $0.128B 0.00
Celyad SA (CYAD) Belgium $0.128B 0.00
Applied Genetic Technologies (AGTC) United States $0.126B 0.00
VTv Therapeutics (VTVT) United States $0.124B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.120B 0.00
Strongbridge Biopharma (SBBP) United States $0.115B 0.00
Lumos Pharma (LUMO) United States $0.115B 0.00
Windtree Therapeutics (WINT) United States $0.111B 0.00
Orgenesis (ORGS) United States $0.110B 5.62
Antibe Therapeutics (ATBPF) Canada $0.105B 0.00
Gritstone Oncology (GRTS) United States $0.104B 0.00
Enzo Biochem (ENZ) United States $0.103B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.103B 0.00
PHASEBIO PHARMA (PHAS) United States $0.100B 0.00
Evogene (EVGN) Israel $0.100B 0.00
Catalyst Biosciences (CBIO) United States $0.098B 0.00
Unum Therapeutics (UMRX) United States $0.097B 0.00
AIT Therapeutics (XAIR) United States $0.088B 0.00
Oncobiologics (OTLK) United States $0.086B 0.00
Bionano Genomics (BNGO) United States $0.082B 0.00
ARAVIVE, INC (ARAV) United States $0.081B 0.00
Idera Pharmaceuticals (IDRA) United States $0.080B 0.00
Ecology Coatings (ABVC) United States $0.077B 0.00
DiaMedica Therapeutics (DMAC) United States $0.077B 0.00
Edesa Biotech (EDSA) Canada $0.076B 0.00
Clearside Biomedical (CLSD) United States $0.072B 0.00
Synlogic (SYBX) United States $0.071B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.071B 0.00
Adocia (ADOCY) France $0.067B 0.00
Prima BioMed (IMMP) Australia $0.067B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.064B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.060B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.059B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.059B 0.00
Proteostasis Therapeutics (PTI) United States $0.058B 0.00
Curis (CRIS) United States $0.057B 0.00
TRACON Pharmaceuticals (TCON) United States $0.056B 0.00
Appili Therapeutics (APLIF) Canada $0.053B 0.00
Soligenix (SNGX) United States $0.051B 0.00
Novogen (KZIA) Australia $0.049B 0.00
Cocrystal Pharma (COCP) United States $0.048B 0.00
Vascular Biogenics (VBLT) Israel $0.048B 0.00
Stealth BioTherapeutics (MITO) United States $0.047B 67.50
AnPac Bio-Medical Science (ANPC) China $0.047B 0.00
Signal Genetics (MGEN) United States $0.046B 0.00
Happiness Biotech Group (HAPP) China $0.045B 0.00
CollPlant Holdings (CLGN) Israel $0.044B 0.00
Genetic Technologies (GENE) Australia $0.044B 0.00
Organovo Holdings (ONVO) United States $0.042B 0.00
IMMURON (IMRN) Australia $0.041B 0.00
Pulmatrix (PULM) United States $0.037B 0.00
Vaccinex (VCNX) United States $0.036B 0.00
ATyr Pharma (LIFE) United States $0.035B 0.00
Chanticleer Holdings (SONN) United States $0.034B 0.00
Prana Biotechnology (ATHE) Australia $0.030B 0.00
Acorda Therapeutics (ACOR) United States $0.030B 0.00
BioCardia (BCDA) United States $0.029B 0.00
OvaScience (MLND) United States $0.029B 0.00
Apricus Biosciences (SEEL) United States $0.029B 0.00
Cleveland BioLabs (CBLI) United States $0.026B 0.00
Advaxis (ADXS) United States $0.026B 0.00
Alimera Sciences (ALIM) United States $0.025B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.025B 0.00
Celsion (CLSN) United States $0.024B 0.00
Aptevo Therapeutics (APVO) United States $0.024B 0.00
Cesca Therapeutics (THMO) United States $0.021B 0.00
Spherix (AIKI) United States $0.019B 0.00
AEterna Zentaris (AEZS) United States $0.019B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.017B 0.00
Titan Pharmaceuticals (TTNP) United States $0.017B 0.00
MYOS RENS Technology (MYOS) United States $0.016B 0.00
Neuralstem (SNCA) United States $0.009B 0.00
Benitec Biopharma (BNTC) Australia $0.007B 0.00
Entera Bio (ENTX) Israel $0.000B 0.00